InMed Pharmaceuticals (INM) Other Accumulated Expenses (2021 - 2023)
InMed Pharmaceuticals (INM) posted quarterly Other Accumulated Expenses of $2.3 million for Q1 2023, down 5.46% quarter-over-quarter from $2.4 million in Q4 2022.
InMed Pharmaceuticals (INM) Other Accumulated Expenses (2021 - 2023) Analysis & Trends
InMed Pharmaceuticals' Other Accumulated Expenses history runs 3 years deep, the most recent figure standing at $2.3 million for Q1 2023.
- In Q1 2023, Other Accumulated Expenses changed N/A year-over-year to $2.3 million; the TTM figure through Mar 2023 stood at $2.3 million (changed N/A YoY), while the FY2022 annual figure was $3.2 million, up 43.6% from the prior year.
- Other Accumulated Expenses for Q1 2023 stood at $2.3 million, down from $2.4 million in the prior quarter.
- The five-year high for Other Accumulated Expenses was $3.3 million in Q3 2022, with the low at $2.2 million in Q2 2021.
- The 3-year median for Other Accumulated Expenses is $2.4 million (2022), against an average of $2.7 million.
- Peak annual rise in Other Accumulated Expenses reached 43.6% in 2022, while the deepest fall reached 43.6% in 2022.
- InMed Pharmaceuticals' Other Accumulated Expenses stood at $2.2 million in 2021, then grew by 8.37% to $2.4 million in 2022, then declined by 5.46% to $2.3 million in 2023.
- Business Quant data shows INM's Other Accumulated Expenses at $2.3 million in Q1 2023, $2.4 million in Q4 2022, and $3.3 million in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | InMed Pharmaceuticals | 6.36 Mn | 1.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 2.27 Mn |
| Dec 31, 2022 | 2.40 Mn |
| Sep 30, 2022 | 3.28 Mn |
| Jun 30, 2022 | 3.18 Mn |
| Jun 30, 2021 | 2.22 Mn |